Act Fast: RSV Study available within 72 hours of first symptom
Helios Clinical Research is conducting a clinical study on RSV (Respiratory Syncytial Virus). The purpose of this study is to evaluate the effectiveness of a new potential treatment for RSV in high-risk adults. We're seeking individuals 65 years of age or older, or 18 years of age or older with COPD, Asthma, or Congestive Heart Failure, to join us in a mission to improve RSV treatments. Your involvement could help make a significant breakthrough in RSV treatment.